PT Kalbe Farma Tbk. (PTKFY)
USD 15.0
(17.46%)
USD 15.0
(17.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 30449.13 Billion | 1.95 Billion | 1.83 Billion | 1.58 Billion | 1.59 Billion | 1.48 Billion |
| Cost of Revenue | 18625.88 Billion | 1.18 Billion | 1.07 Billion | 906.06 Million | 895.96 Million | 811.92 Million |
| Gross Profit | 11823.24 Billion | 764.23 Million | 761.22 Million | 676.42 Million | 702.26 Million | 674.69 Million |
| Operating Expenses | 7920.65 Billion | 481.38 Million | 483.27 Million | 436.45 Million | 470.34 Million | 451.4 Million |
| Selling, General and Administrative Expenses | 7591.03 Billion | 450 Million | 450.08 Million | 402.61 Million | 435.68 Million | 419.37 Million |
| Research and Development Expenses | 329.62 Billion | 16.35 Million | 17.61 Million | 17.18 Million | 18.26 Million | 15.69 Million |
| Other Expenses | - | -15.02 Million | -15.56 Million | -16.65 Million | -16.4 Million | -16.34 Million |
| Cost and Expenses | 26818.29 Billion | 1.67 Billion | 1.55 Billion | 1.34 Billion | 1.36 Billion | 1.26 Billion |
| Operating Income | 3630.83 Billion | 282.84 Million | 277.94 Million | 239.97 Million | 231.92 Million | 223.28 Million |
| Interest Expense | 95.1 Billion | 3.71 Million | 4 Million | 6.13 Million | 2.85 Million | 19.65 Billion |
| Income Tax Expense | 827.83 Billion | 68.12 Million | 63.65 Million | 56.69 Million | 61.08 Million | 57.07 Million |
| Earnings before Tax | 3606.23 Billion | 301.11 Million | 289.42 Million | 248.37 Million | 240.27 Million | 233.23 Million |
| Net Income | 2766.74 Billion | 228.4 Million | 222.39 Million | 187.14 Million | 177.01 Million | 173.32 Million |
| Earnings Per Share Basic | 59.81 | 0.98 | 0.95 | 0.80 | 0.76 | 0.74 |
| Earnings Per Share Diluted | 59.81 | 0.98 | 0.95 | 0.80 | 0.76 | 0.74 |
| Weighted Average Shares Outstanding | 46.25 Billion | 232.57 Million | 234.36 Million | 234.36 Million | 234.37 Million | 234.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.25 Billion | 232.57 Million | 234.36 Million | 234.36 Million | 234.37 Million | 234.37 Million |
| Gross Margin | 0.39 | 0.39 | 0.41 | 0.43 | 0.44 | 0.45 |
| EBIT Margin | 0.15 | 0.17 | 0.18 | 0.18 | 0.17 | 0.17 |
| Profit Margin | 0.09 | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 |
| EBITDA | 4432.82 Billion | 4833.89 Billion | 4536.83 Billion | 4042.34 Billion | 3703.93 Billion | 3588.4 Billion |
| Earnings Before Tax Margin | 0.12 | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 501.99 Million | 496.71 Million | 537.64 Million | 7888.12 Billion | 30449.13 Billion | 482.18 Million |
| Cost of Revenue | 315.13 Million | 307.68 Million | 330.72 Million | 4971.68 Billion | 18625.88 Billion | 309.54 Million |
| Gross Profit | 186.86 Million | 189.02 Million | 206.91 Million | 2916.44 Billion | 11823.24 Billion | 172.64 Million |
| Operating Expenses | 142.81 Million | 123.16 Million | 129.06 Million | 1951.31 Billion | 8198.1 Billion | 128.29 Million |
| Selling, General and Administrative Expenses | 130.41 Million | 110.27 Million | 120.71 Million | 1282.84 Billion | - | 120.06 Million |
| Research and Development Expenses | 4.98 Million | 6.28 Million | 4.64 Million | 119.75 Billion | - | 3.81 Million |
| Other Expenses | -7.41 Million | -6.6 Million | -3.71 Million | -974.39 Thousand | -6.32 Million | -4.41 Million |
| Cost and Expenses | 457.95 Million | 430.85 Million | 459.79 Million | 6922.99 Billion | 26823.99 Billion | 437.83 Million |
| Operating Income | 44.04 Million | 65.85 Million | 77.84 Million | 969.37 Billion | 3672.25 Billion | 44.34 Million |
| Interest Expense | 807.64 Thousand | 19.35 Billion | 12.48 Billion | 15.31 Billion | 82.95 Billion | 1.73 Million |
| Income Tax Expense | 10.09 Million | 16 Million | 18 Million | 250.04 Billion | 827.83 Billion | 10.12 Million |
| Earnings before Tax | 45.98 Million | 68.58 Million | 81.49 Million | 955.15 Billion | 3606.23 Billion | 46.48 Million |
| Net Income | 36.38 Million | 52.85 Million | 61.55 Million | 701.82 Billion | 2766.74 Billion | 35 Million |
| Earnings Per Share Basic | 0.16 | 0.23 | 0.27 | 0.19 | - | 0.15 |
| Earnings Per Share Diluted | 0.16 | 0.23 | 0.27 | 0.19 | - | 0.15 |
| Weighted Average Shares Outstanding | 230.74 Million | 231.21 Million | 231.27 Million | 231.27 Million | 231.27 Million | 231.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 230.74 Million | 231.21 Million | 231.27 Million | 231.27 Million | 231.27 Million | 231.27 Million |
| Gross Margin | 0.37 | 0.38 | 0.38 | 0.37 | 0.39 | 0.36 |
| EBIT Margin | 0.12 | 0.16 | 0.17 | 0.13 | - | 0.12 |
| Profit Margin | 0.07 | 0.11 | 0.11 | 0.09 | 0.09 | 0.07 |
| EBITDA | 59.5 Million | 77.48 Million | 90.19 Million | 1053.4 Billion | - | 56.63 Million |
| Earnings Before Tax Margin | 0.09 | 0.13 | 0.14 | 0.12 | 0.12 | 0.09 |
KOVAI
FBSE
300645
NUVOCO
ROKU
VCP